1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Medicinova Inc (MNOV)
  7. Quote


Medicinova Stock Price

-0.02 (-0.66%)
Volume 2,517
Bid Price 3.03
Ask Price 3.53
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Medicinova Inc MNOV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.66% 3.01 05:02:02
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
12 2,517 - 2.9801 - 10.81
Last Trade Time Type Quantity Stock Price Currency
04:55:35 90 $ 3.01 USD


Draw Mode:

Medicinova Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 147.62M 49.04M 41.21M $ - $ - -0.30 -14.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 6.90%

more financials information »

Medicinova News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNOV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.353.592.98013.26584,267-0.34-10.15%
1 Month3.494.652.98014.111,303,567-0.48-13.75%
3 Months4.054.652.98014.07469,332-1.04-25.68%
6 Months4.185.092.98014.06642,931-1.17-27.99%
1 Year5.9510.812.98015.31607,228-2.94-49.41%
3 Years10.1413.372.797.14433,697-7.13-70.32%
5 Years7.0314.502.797.43305,724-4.02-57.18%

Medicinova Description

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.